Top Institutional Investors

Bleichroeder LP — 13F Holdings & Portfolio

CIK 1781002 · latest 13F-HR filed 2026-08-13

Backtest portfolio

Bleichroeder LP manages $558.9M in 13F-reported U.S. long-equity assets across 78 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are GLD (31.31%), GPGI (11.26%), SPY (9.04%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 9 new positions, exited 12, added to 34, and trimmed 23.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
1345 AVENUE OF THE AMERICAS
47TH FLOOR
NEW YORK, NY 10105
Phone
(917) 769-2999
Filing Manager
Bleichroeder LP
NEW YORK, NY
Signatory
Andrew Gundlach
Chairman and CEO of Bleichroeder LP
Loading holdings…
AUM

$558.9M

Long-equity book

Holdings

78

Distinct positions

Period

2026-06-30

Filed 2026-08-13

Q/Q Activity

+9 / −12 / ↑34 / ↓23

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • DUOS TECHNOLOGIES GROUP INC$8.4M +74.9%
  • PRECISION BIOSCIENCES INC$6.7M +73.5%
  • STATE STR SPDR S&P 500 ETF T$6.5M +14.8%
  • CULLINAN THERAPEUTICS INC$3.1M +220.4%
  • KAZIA THERAPEUTICS LTD$2.7M +89.2%
Show all 34 →

Top Trims

  • SPDR GOLD TR-$29.4M -14.4%
  • MDXHEALTH SA-$13.9M -82.1%
  • INTELLICHECK MOBILISA INC-$6.1M -41.8%
  • RESOLUTE HLDGS MGMT INC-$5.6M -10.9%
  • GPGI INC-$4.9M -7.3%
Show all 23 →

New Positions

  • CUE BIOPHARMA INC$11.7M
  • COGENT BIOSCIENCES INC$3.9M
  • SPIRE GLOBAL INC$2.5M
  • NEUROONE MED TECHNOLOGIES CO$2.0M
  • LIBERTY DEFENSE HLDGS LTD$1.1M
Show all 9 →

Exited Positions

  • NEUROONE MED TECHNOLOGIES CO$3.1M
  • CUE BIOPHARMA INC$1.6M
  • PRECISION OPTICS CORP INC MA$1.2M
  • RTX CORPORATION$1.2M
  • SHARONAI HOLDINGS INC$568.2K
Show all 12 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 SPDR GOLD TR GLD 78463V107 $175.0M 31.31% 475,000 SH
2 GPGI INC GPGI 20459V105 $63.0M 11.26% 3,972,176 SH
3 STATE STR SPDR S&P 500 ETF T SPY 78462F103 $50.5M 9.04% 67,645 SH
4 RESOLUTE HLDGS MGMT INC RHLD 76134H101 $45.4M 8.12% 314,166 SH
5 LINDE PLC LIN G54950103 $31.4M 5.61% 60,434 SH
6 DUOS TECHNOLOGIES GROUP INC DUOT 266042407 $19.5M 3.49% 1,627,806 SH
7 PRECISION BIOSCIENCES INC DTIL 74019P207 $15.9M 2.84% 2,018,190 SH
8 CUE BIOPHARMA INC CUE 22978P205 $11.7M 2.09% 370,682 SH
9 BLACKSTONE INC BX 09260D107 $10.7M 1.91% 90,750 SH
10 IMMIX BIOPHARMA INC IMMX 45258H106 $10.3M 1.84% 1,000,000 SH
11 INTELLICHECK MOBILISA INC IDN 45817G201 $8.4M 1.51% 2,056,343 SH
12 S&P GLOBAL INC SPGI 78409V104 $8.1M 1.46% 20,000 SH
13 IDENTIV INC INVE 45170X205 $7.3M 1.30% 2,884,495 SH
14 LIQTECH INTL INC LIQT 53632A300 $5.8M 1.05% 6,882,239 SH
15 KAZIA THERAPEUTICS LTD KZIA 48669G303 $5.6M 1.01% 400,000 SH
16 ENVOY MEDICAL INC COCH 29415V109 $5.0M 0.89% 6,250,000 SH
17 CULLINAN THERAPEUTICS INC CGEM 230031106 $4.6M 0.81% 250,000 SH
18 WELLTOWER INC WELL 95040Q104 $4.5M 0.81% 20,000 SH
19 EYEPOINT INC EYPT 30233G209 $4.5M 0.81% 316,515 SH
20 FLUENT INC FLNT 34380C201 $4.3M 0.76% 1,142,857 SH
21 GENELUX CORPORATION GNLX 36870H103 $4.2M 0.74% 1,380,666 SH
22 PROKIDNEY CORP PROK 74291D104 $4.1M 0.73% 2,000,000 SH
23 COGENT BIOSCIENCES INC COGT 19240Q201 $3.9M 0.69% 100,000 SH
24 INVESCO QQQ TR QQQ 46090E103 $3.4M 0.61% 4,640 SH
25 JPMORGAN CHASE & CO JPM 46625H100 $3.3M 0.60% 10,200 SH
26 MDXHEALTH SA MDXH B5950S113 $3.0M 0.54% 7,378,333 SH
27 OPUS GENETICS INC IRD 67577R102 $3.0M 0.54% 736,842 SH
28 GRUPO TELEVISA S A B TV 40049J206 $2.8M 0.50% 1,030,000 SH
29 BARFRESH FOOD GROUP INC BRFH 067532200 $2.8M 0.50% 1,390,758 SH
30 DIAMEDICA THERAPEUTICS INC DMAC 25253X207 $2.7M 0.48% 382,317 SH
31 RANK ONE COMPUTING CORP ROC 753040104 $2.6M 0.47% 500,000 SH
32 SPIRE GLOBAL INC SPIR 848560306 $2.5M 0.45% 135,000 SH
33 IDEAL PWR INC IPWR 451622203 $2.1M 0.38% 400,000 SH
34 NEUROONE MED TECHNOLOGIES CO NMTC 64130M308 $2.0M 0.36% 666,666 SH
35 CURIS INC CRIS 231269309 $2.0M 0.36% 3,802,329 SH
36 REVOLUTION MEDICINES INC RVMDW 76155X118 $1.9M 0.34% 200,000 SH
37 PROFOUND MED CORP PROF 74319B502 $1.7M 0.30% 254,753 SH
38 RENOVORX INC RNXT 75989R107 $1.6M 0.29% 1,666,098 SH
39 MODULAR MED INC MODD 60785L306 $1.5M 0.27% 336,986 SH
40 VENU HLDG CORP VENU 92333E104 $1.4M 0.24% 600,000 SH
41 TALPHERA INC TLPH 00444T209 $1.3M 0.24% 1,307,787 SH
42 QT IMAGING HLDGS INC QTI 746962307 $1.3M 0.23% 316,667 SH
43 LIBERTY LIVE HOLDINGS INC LLYVK 530909308 $1.2M 0.21% 13,802 SH
44 LIBERTY DEFENSE HLDGS LTD DETX 53044R867 $1.1M 0.20% 277,777 SH
45 REIN THERAPEUTICS INC RNTX 00887A204 $1.0M 0.19% 1,000,000 SH
46 OWLET INC OWLT 69120X206 $987.3K 0.18% 172,000 SH
47 SINTX TECHNOLOGIES INC SINT 829392703 $978.0K 0.17% 523,013 SH
48 CELLECTAR BIOSCIENCES INC CLRB 15117F880 $802.5K 0.14% 288,679 SH
49 MAIA BIOTECHNOLOGY INC MAIA 552641102 $720.0K 0.13% 500,000 SH
50 5E ADVANCED MATERIALS INC FEAM 33830Q208 $637.7K 0.11% 458,774 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-13 $558.9M 78 0001420506-26-001619
2026-03-31 2026-05-14 $578.6M 81 0001420506-26-001007
2025-12-31 2026-02-13 $568.3M 73 0001420506-26-000412
2025-09-30 2025-11-14 $513.0M 72 0001420506-25-003432